TORONTO, March 9, 2021 /CNW/ — Mind Medicine (MindMed) Inc. (NEO: MMED, OTCQB: MMEDF, DE: MMQ) (“MindMed” or the “Company”) is pleased to announce that it has closed its previously announced bought deal private placement offering (the “Offering”). In connection with the Offering, the Company issued 6.0 million units of the Company (the “Units”) at a price per Unit of CAD $3.25 (the “Issue Price”)…


Previous articleThe Pitfalls and Challenges of Psychedelic Medicine
Next articleMydecine Innovations Group Announces Plans to Spin Out of its [U.S.] Cannabis Assets